Vyepti® (eptinezumab) is a quarterly intravenous treatment designed to prevent migraines before they begin. Unlike daily medications or monthly injections, Vyepti is administered only four times per year and targets CGRP, a key migraine signaling molecule. Learn how this innovative therapy works, who may qualify, what side effects to consider, and the insurance steps often required before treatment can begin. This guide reviews the benefits, risks, and practical consideration

Creatine is widely used to improve muscle mass and athletic performance, but it may not be appropriate for everyone. While generally considered safe in healthy individuals, concerns remain for patients with kidney disease, diabetes, hypertension, dehydration, or those taking medications that affect renal function. This article reviews potential risks, explains who should exercise caution, and discusses safer alternatives for preserving muscle mass and healthy aging.